MZTI Stock Analysis: The Marzetti | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 2.716m USD | 12M Return: -37.3% | US5138471033 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 43.1M
EPS Trend: 85.1%
Qual. Beats: 0
Rev. Trend: 94.0%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Marzetti Company (NASDAQ: MZTI) is a U.S.-based specialty food manufacturer operating two business segments: Retail and Foodservice. Its Retail segment sells branded products including frozen garlic bread and rolls (New York Bakery, Sister Schuberts), salad dressings (Marzetti, Cardinis, Marzetti Simply, Girards), dips, Bachans Japanese barbecue sauces, and croutons and toppings. The Foodservice segment supplies custom-formulated sauces, dressings, frozen breads, yeast rolls, and frozen pasta to chain restaurants, including private-label offerings. Products are distributed through sales personnel, food brokers, and distributors. The company was founded in 1896, is headquartered in Westerville, Ohio, and was renamed from Lancaster Colony Corporation in June 2025.
As a Consumer Staples company classified within the Agricultural Products & Services sub-industry, MZTI operates in a defensive sector typically characterized by stable, recurring demand across economic cycles. Its dual-channel model, spanning branded consumer retail and business-to-business foodservice, provides diversified revenue exposure across grocery, restaurant, and institutional end markets.
- Retail branded sales grow on Bachans and Sister Schuberts momentum
- Foodservice revenue tracks restaurant traffic and chain demand recovery
- Soybean oil and grain input costs pressure gross margins
| Net Income: 191.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -3.77 > 1.0 |
| NWC/Revenue: 13.33% < 20% (prev 16.43%; Δ -3.10% < -1%) |
| CFO/TA 0.22 > 3% & CFO 283.8m > Net Income 191.6m |
| Net Debt (94.0m) to EBITDA (263.4m): 0.36 < 3 |
| Current Ratio: 2.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.4m) vs 12m ago -0.23% < -2% |
| Gross Margin: 24.73% > 18% (prev 23.87%; Δ 0.87% > 0.5%) |
| Asset Turnover: 153.5% > 50% (prev 154.0%; Δ -0.49% > 0%) |
| Interest Coverage Ratio: 138.2 > 6 (EBIT TTM 243.7m / Interest Expense TTM 1.76m) |
| A: 0.20 (Total Current Assets 443.6m - Total Current Liabilities 186.3m) / Total Assets 1.27b |
| B: 1.28 (Retained Earnings 1.63b / Total Assets 1.27b) |
| C: 0.19 (EBIT TTM 243.7m / Avg Total Assets 1.26b) |
| D: 3.61 (Book Value of Equity 998.5m / Total Liabilities 276.2m) |
| Altman-Z'' = 10.59 = AAA |
| DSRI: 0.96 (Receivables 95.8m/99.2m, Revenue 1.93b/1.91b) |
| GMI: 0.97 (GM 23.87% / 24.73%) |
| AQI: 1.04 (AQ_t 0.19 / AQ_t-1 0.18) |
| SGI: 1.01 (Revenue 1.93b / 1.91b) |
| TATA: -0.07 (NI 191.6m - CFO 283.8m) / TA 1.27b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of October 12, 2026, the stock is trading at USD 99.30 with a total of 359,208 shares traded. Over the past week, the price has changed by -0.23%, over one month by -1.88%, over three months by -10.55% and over the past year by -37.25%.
Current recommended Stop Loss: 95.60 (which is 3.7% or 1.3 ATR below the current price).
The Marzetti has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold MZTI.
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 146.6 | 47.6% |
P/E Trailing = 14.2593
P/E Forward = 36.1011
P/S = 1.4075
P/B = 2.6836
P/EG = 3.1204
Revenue TTM = 1.93b USD
EBIT TTM = 243.7m USD
EBITDA TTM = 263.4m USD
Long Term Debt = 189.3m USD (from longTermDebt, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last quarter)
Debt = 255.5m USD (corrected: LT Debt 189.3m + ST Debt 11.7m) + Leases 54.5m
Net Debt = 94.0m USD (calculated: Debt 255.5m - CCE 161.5m)
Enterprise Value = 2.81b USD (2.72b + Debt 255.5m - CCE 161.5m)
Interest Coverage Ratio = 138.2 (Ebit TTM 243.7m / Interest Expense TTM 1.76m)
EV/FCF = 13.63x (Enterprise Value 2.81b / FCF TTM 206.1m)
FCF Yield = 7.34% (FCF TTM 206.1m / Enterprise Value 2.81b)
FCF Margin = 10.68% (FCF TTM 206.1m / Revenue TTM 1.93b)
Net Margin = 9.93% (Net Income TTM 191.6m / Revenue TTM 1.93b)
Gross Margin = 24.73% ((Revenue TTM 1.93b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 24.51% (prev 23.65%)
Tobins Q-Ratio = 2.20 (Enterprise Value 2.81b / Total Assets 1.27b)
Interest Expense / Debt = 0.69% (Interest Expense 1.76m / Debt 255.5m)
Taxrate = 20.81% (50.4m / 242.0m)
NOPAT = 193.0m (EBIT 243.7m * (1 - 20.81%))
Current Ratio = 2.38 (Total Current Assets 443.6m / Total Current Liabilities 186.3m)
Debt / Equity = 0.26 (Debt 255.5m / totalStockholderEquity, last quarter 998.5m)
Debt / EBITDA = 0.36 (Net Debt 94.0m / EBITDA 263.4m)
Debt / FCF = 0.46 (Net Debt 94.0m / FCF TTM 206.1m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.24% (Net Income 191.6m / Total Assets 1.27b)
RoE = 18.82% (Net Income TTM 191.6m / Total Stockholder Equity 1.02b)
RoCE = 20.19% (EBIT 243.7m / Capital Employed (Equity 1.02b + L.T.Debt 189.3m))
RoIC = 19.23% (NOPAT 193.0m / Invested Capital 1.00b)
WACC = 5.34% (E(2.72b)/V(2.97b) * Re(5.79%) + D(255.5m)/V(2.97b) * Rd(0.69%) * (1-Tc(0.21)))
Discount Rate = 5.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -63.95 | Cagr: -0.07%
[DCF] Terminal Value 73.10% ; FCFF base≈222.6m ; Y1≈195.2m ; Y5≈157.7m
[DCF] Fair Price = 89.30 (EV 2.53b - Net Debt 94.0m = Equity 2.44b / Shares 27.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 85.11 | EPS CAGR: 7.25% | SUE: 0.69 | # QB: 0
Revenue Correlation: 93.99 | Revenue CAGR: 1.74% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.38 | Chg30d=-22.47% | Revisions=-40% | Analysts=4
EPS next Quarter (2026-12-31): EPS=2.21 | Chg30d=-5.05% | Revisions=-40% | Analysts=4
EPS current Year (2027-06-30): EPS=6.73 | Chg30d=-6.47% | Revisions=-57% | GrowthEPS=-1.4% | GrowthRev=+4.8%
EPS next Year (2028-06-30): EPS=7.23 | Chg30d=-2.24% | Revisions=-25% | GrowthEPS=+7.4% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: -75% (up=0, down=9)